Departed
Joan B. Harvey
Director
PAVM ·
PAVmed Inc.
James L. Cox, M.D., and Joan B. Harvey resigned from the Company’s board of directors.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6851–6900 of 33095
Departed
Hassan Oulhous
Director
Blue Chip Capital Group Inc.
accepted the resignation of Hassan Oulhous as a member of the Company’s Board of Directors.
Departed
Scott Bosick
Director
FMHS ·
FARMHOUSE, INC. /NV
On October 13, 2023, Farmhouse announced that Mr. Scott Bosick, a member of the Board of Directors, tendered his resignation from the Board, effective immediately.
Departed
Rachit Lohani
Senior Vice President and Chief Technology Officer
PCTY ·
Paylocity Holding Corp
On September 11, 2024, Rachit Lohani, Senior Vice President and Chief Technology Officer of Paylocity Holding Corporation (the “Company”), notified the Company of his decision to depart the Company.
Departed
Jeremy Whitaker
Chief Financial Officer
LTRX ·
LANTRONIX INC
On September 10, 2024, Jeremy Whitaker informed Lantronix, Inc. (the “Company”) that he was resigning as the Company’s Chief Financial Officer effective September 13, 2024.
Departed
James Fuller
Director
CVAT ·
Cavitation Technologies, Inc.
Effective August 22, 2024, James Fuller voluntarily resigned as a Director of Cavitation Technologies, Inc. (“Company”) and any committees thereof for personal reasons.
Departed
John Carrington
Chief Executive Officer
STEM ·
STEM, INC.
Mr. John Carrington stepped down as Chief Executive Officer of the Company and as a member of the Company’s board of directors (the “Board”), effective September 11, 2024.
Departed
Chunyi (Amy) Leong
Director
SKYT ·
SkyWater Technology, Inc
On September 15, 2024, Chunyi (Amy) Leong informed SkyWater Technology, Inc. (the “Company”) of her decision to resign from the Company’s Board of Directors (the “Board”) effective September 29, 2024.
Departed
Janet Chou
Chief Financial Officer and Treasurer
NVTS ·
Navitas Semiconductor Corp
Janet Chou, who announced her intention to resign as CFO and Treasurer of the Company, effective October 4, 2024.
Departed
Ford Tamer
Director
MRVL ·
Marvell Technology, Inc.
Dr. Ford Tamer, a member of the Board of Directors of Marvell Technology, Inc. (the “Company”), notified the Company of his decision to resign from the Board effective as of September 15, 2024.
Departed
Scott Bower
principal accounting officer
PGY ·
Pagaya Technologies Ltd.
On September 10, 2024, Scott Bower notified Pagaya Technologies Ltd. (“Pagaya” or the “Company”) of his resignation as principal accounting officer of the Company, effective September 20, 2024.
Departed
Suzanne Blaug
Director
KYNB ·
KYNTRA BIO, INC.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
Departed
Gerald Lema
Director
KYNB ·
KYNTRA BIO, INC.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
Departed
Benjamin Cravatt
Director
KYNB ·
KYNTRA BIO, INC.
On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
Departed
(interim)
Kimberly Bambach
interim Chief Financial Officer
VBIO ·
Valion Bio, Inc.
On September 12, 2024, Kimberly Bambach tendered her resignation from her role as interim Chief Financial Officer of the Company, effective October 1, 2024.
Departed
Trevor I. Mihalik
Executive Vice President and Group President
SRE ·
SEMPRA
On September 10, 2024, Trevor I. Mihalik provided notice that he will retire as the Executive Vice President and Group President of Sempra and as the non-executive Chairman of the Board and a director of Southern California Gas Company, a subsidiary of Sempra, in each case effective January 1, 2025.
Departed
Misty Kawecki
Chief Financial Officer
DZS INC.
The Board removed Misty Kawecki as the Company’s Chief Financial Officer at such time.
Departed
Nikita Jaiswal
Director
Future Health ESG Corp.
On September 11, 2024, Ms. Nikita Jaiswal resigned from the board of directors (the “Board”) of Future Health Esg Corp (the “Company”).
Departed
Scott Crenshaw
Executive Vice President and General Manager, Digital Services
EQIX ·
EQUINIX INC
Equinix, Inc. (the “Company”) has announced that Scott Crenshaw, the Executive Vice President and General Manager, Digital Services of the Company, will separate from his employment with the Company.
Departed
Eva Redhe
independent director
Enphys Acquisition Corp.
On September 10, 2024, Eva Redhe, an independent director on the Board of Directors of Enphys Acquisition Corp., a Cayman Islands exempted company (the “Company”), informed the Company that she has resigned from the Board of Directors of the Company, including from her committee positions on the audit committee, the compensation committee, and the nominating and corporate governance committee, effective immediately.
Departed
Margaret E. Wicklund
Senior Vice President and Chief Accounting Officer
DDD ·
3D SYSTEMS CORP
On September 9, 2024, 3D Systems Corporation (the “Company”) notified Margaret E. Wicklund that her role and position as the Company’s Senior Vice President and Chief Accounting Officer will be eliminated, effective immediately as part of a planned restructuring within the Company’s finance function.
Departed
Fred E. Cohen
Director
URGN ·
UroGen Pharma Ltd.
On September 12, 2024, Fred E. Cohen, M.D., D.Phil., notified UroGen Pharma Ltd. (the “Company”) of his resignation as a director of the Company, effective immediately.
Departed
Chrystyna Bedrij Stecyk
director
VCNX ·
VACCINEX, INC.
On September 10, 2024, Chrystyna Bedrij Stecyk informed Vaccinex, Inc. (the “Company”) of her resignation as a director of the Company effective immediately.
Departed
Ashley F. Hall
Chief Development Officer
OKUR ·
OnKure Therapeutics, Inc.
the Company terminated the employment of Ashley F. Hall, J.D., the Company’s Chief Development Officer, effective as of September 13, 2024.
Departed
Joan Y. Brown
Chief Financial Officer
ALLR ·
Allarity Therapeutics, Inc.
On September 12, 2024, the Company received a notice of resignation from Joan Y. Brown, its Chief Financial Officer, effective September 12, 2024.
Departed
Nikita Jaiswal
Director
EVe Mobility Acquisition Corp
On September 11, 2024, Ms. Nikita Jaiswal resigned from the board of directors (the “Board”) of EVe Mobility Acquisition Corp (the “Company”).
Departed
Ryan Maarschalk
Chief Financial Officer
Allied Corp.
On August 21, 2024, effective August 19, 2024, the Company and Ryan Maarschalk entered into a Termination Agreement pursuant to which Mr. Maarschalk ceased to be Chief Financial Officer of the Company.
Departed
Kenneth L. Londoner
Chairman
STEX ·
Streamex Corp.
As previously announced on February 27, 2024, Kenneth L. Londoner, the former chairperson (“Chairman”) of the Board of Directors (the “Board”) of BioSig Technologies, Inc. (the “Company”) resigned from the Company.
Departed
Bill Bryant
Director
BNZI ·
Banzai International, Inc.
On September 9, 2024, Mr. Bill Bryant resigned from his positions as a director of the board of directors (the " Board ") of the Company
Departed
Adrian Kilcoyne
Executive Vice President and Chief Medical Officer
CELU ·
Celularity Inc
Adrian Kilcoyne, M.D., M.P.H., M.B.A. of Celularity Inc., or Celularity, provided notice of resignation from his role as Executive Vice President and Chief Medical Officer, effective as of August 6, 2024, to pursue other opportunities.
Departed
Christian Okonsky
Member of the Board of Directors
EMPD ·
Empery Digital Inc.
On September 9, 2024, Christian Okonsky resigned as a member of the Volcon, Inc. (the “Company”) Board of Directors (the “Board”).
Departed
Dan Norton
President
Forza X1, Inc.
On September 10, 2024, Forza X1, Inc. (the “Company”) entered into a Separation Agreement with Dan Norton, the Company’s President, pursuant to which Mr. Norton and the Company mutually agreed to terminate his employment with the Company, effective as of September 30, 2024 (the “Separation Agreement”).
Departed
Alan List
Chief Medical Officer
DTIL ·
PRECISION BIOSCIENCES INC
On September 9, 2024, Alan List, M.D., the Company’s Chief Medical Officer, notified Precision BioSciences, Inc. (the “Company”) that he will be retiring from the Company, effective September 13, 2024.
Departed
Michael DiTullio
President and Chief Operating Officer
PTC ·
PTC INC.
This appointment takes effect following the conclusion of Michael DiTullio’s tenure as President and Chief Operating Officer of the Company on September 30, 2024.
Departed
Salim Yazji
Chief Medical Officer
Oncternal Therapeutics, Inc.
Salim Yazji, M.D. will cease serving as Chief Medical Officer, to be effective as of October 1, 2024.
Departed
Ann M. Powell
Director
OTEX ·
OPEN TEXT CORP
Ann M. Powell informed the Company of her decision not to stand for election to the Board of Directors of the Company at the Meeting.
Departed
Michelle Swanback
President of TTEC Holdings and CEO of TTEC Engage
TTEC ·
TTEC Holdings, Inc.
On September 11, 2024, Michelle Swanback, president of TTEC Holdings, Inc. (“TTEC”) and TTEC Engage business segment’s chief executive officer, notified the company that she is resigning, effective December 31, 2024.
Departed
Alan H. Shaw
President and Chief Executive Officer
NSC ·
NORFOLK SOUTHERN CORP
terminated Alan H. Shaw, President and Chief Executive Officer of the Company, in connection with preliminary findings from an ongoing investigation conducted by independent counsel that determined Shaw violated Company policies by engaging in a consensual relationship with the Company’s Chief Legal Officer.
Departed
Paul Christopher Williams
Chief Operating Officer
CTKB ·
Cytek Biosciences, Inc.
On September 9, 2024, Paul Christopher Williams submitted his resignation from his position as the Chief Operating Officer of Cytek Biosciences, Inc. (the “Company”), effective as of September 27, 2024, to pursue another career opportunity.
Departed
Olivier Thirot
Executive Vice President and Chief Financial Officer
KELYA ·
KELLY SERVICES INC
who on July 8, 2024, informed the Company of his intention to retire as an officer of the Company.
Departed
Nathan Hardy
Executive Vice President and Chief Financial Officer
SANA ·
Sana Biotechnology, Inc.
On September 6, 2024, Nathan Hardy notified Sana Biotechnology, Inc. (the “Company”) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024.
Departed
Jamal Khurshid
director
DFNS ·
T3 Defense Inc.
Pursuant to the Settlement Agreement, Mr. Khurshid advised the Company that he was resigning as Chief Executive Officer and as a director of the Company effective September 4, 2024.
Departed
Jamal Khurshid
Chief Executive Officer
DFNS ·
T3 Defense Inc.
Pursuant to the Settlement Agreement, Mr. Khurshid advised the Company that he was resigning as Chief Executive Officer and as a director of the Company effective September 4, 2024.
Departed
Diana Eilert
Director
Keypath Education International, Inc.
each of Diana Eilert, Robert Bazzani, Melanie Laing, and Susan Wolford resigned as a director of the Company
Departed
Robert Bazzani
Director
Keypath Education International, Inc.
each of Diana Eilert, Robert Bazzani, Melanie Laing, and Susan Wolford resigned as a director of the Company
Departed
Susan Wolford
Director
Keypath Education International, Inc.
each of Diana Eilert, Robert Bazzani, Melanie Laing, and Susan Wolford resigned as a director of the Company
Departed
Melanie Laing
Director
Keypath Education International, Inc.
each of Diana Eilert, Robert Bazzani, Melanie Laing, and Susan Wolford resigned as a director of the Company
Departed
Ozan Pamir
Chief Financial Officer and Secretary
FRMM ·
FORUM MARKETS Inc
On September 10, 2024, Mr. Ozan Pamir, the Chief Financial Officer (Principal Financial/Accounting Officer) and Secretary of 180 Life Sciences Corp. (the “Company ", “we” and “us”), tendered his resignation to the board of directors of the Company (the “Board”), effective September 30, 2024.
Departed
Graham Martin
non-executive Chairman
AAPI ·
Apple iSports Group, Inc.
On September 5, 2024, the Company filed a Form 8-K reporting the resignation of Mr. Graham Martin in his capacity as non-executive Chairman of the Company.
Departed
Cary Sucoff
Director
BACK ·
IMAC Holdings, Inc.
On September 6, 2024, Cary Sucoff notified the Board of Directors (the “Board”) of IMAC Holdings, Inc. (the “Company”) of his resignation as director, effective on September 9, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.